GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) » Definitions » Days Inventory

Extrawell Pharmaceutical Holdings (HKSE:00858) Days Inventory : 51.35 (As of Sep. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Extrawell Pharmaceutical Holdings Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Extrawell Pharmaceutical Holdings's Average Total Inventories for the six months ended in Sep. 2023 was HK$4.29 Mil. Extrawell Pharmaceutical Holdings's Cost of Goods Sold for the six months ended in Sep. 2023 was HK$15.25 Mil. Hence, Extrawell Pharmaceutical Holdings's Days Inventory for the six months ended in Sep. 2023 was 51.35.

The historical rank and industry rank for Extrawell Pharmaceutical Holdings's Days Inventory or its related term are showing as below:

HKSE:00858' s Days Inventory Range Over the Past 10 Years
Min: 38.58   Med: 55.38   Max: 80.4
Current: 42.76

During the past 13 years, Extrawell Pharmaceutical Holdings's highest Days Inventory was 80.40. The lowest was 38.58. And the median was 55.38.

HKSE:00858's Days Inventory is ranked better than
94.95% of 970 companies
in the Drug Manufacturers industry
Industry Median: 159.52 vs HKSE:00858: 42.76

Extrawell Pharmaceutical Holdings's Days Inventory declined from Sep. 2022 (55.81) to Sep. 2023 (51.35).

Inventory Turnover measures how fast the company turns over its inventory within a year. Extrawell Pharmaceutical Holdings's Inventory Turnover for the six months ended in Sep. 2023 was 3.55.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Extrawell Pharmaceutical Holdings's Inventory-to-Revenue for the six months ended in Sep. 2023 was 0.14.


Extrawell Pharmaceutical Holdings Days Inventory Historical Data

The historical data trend for Extrawell Pharmaceutical Holdings's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Extrawell Pharmaceutical Holdings Days Inventory Chart

Extrawell Pharmaceutical Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.71 61.53 67.60 80.40 50.58

Extrawell Pharmaceutical Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.10 82.68 55.81 31.17 51.35

Competitive Comparison of Extrawell Pharmaceutical Holdings's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Extrawell Pharmaceutical Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Extrawell Pharmaceutical Holdings's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Extrawell Pharmaceutical Holdings's Days Inventory distribution charts can be found below:

* The bar in red indicates where Extrawell Pharmaceutical Holdings's Days Inventory falls into.



Extrawell Pharmaceutical Holdings Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Extrawell Pharmaceutical Holdings's Days Inventory for the fiscal year that ended in Mar. 2023 is calculated as

Days Inventory (A: Mar. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Mar. 2022 ) + Total Inventories (A: Mar. 2023 )) / count ) / Cost of Goods Sold (A: Mar. 2023 )*Days in Period
=( (8.465 + 3.018) / 2 ) / 41.434*365
=5.7415 / 41.434*365
=50.58

Extrawell Pharmaceutical Holdings's Days Inventory for the quarter that ended in Sep. 2023 is calculated as:

Days Inventory (Q: Sep. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Mar. 2023 ) + Total Inventories (Q: Sep. 2023 )) / count ) / Cost of Goods Sold (Q: Sep. 2023 )*Days in Period
=( (3.018 + 5.564) / 2 ) / 15.25*365 / 2
=4.291 / 15.25*365 / 2
=51.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Extrawell Pharmaceutical Holdings  (HKSE:00858) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Extrawell Pharmaceutical Holdings's Inventory Turnover for the six months ended in Sep. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Extrawell Pharmaceutical Holdings's Inventory to Revenue for the six months ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Extrawell Pharmaceutical Holdings Days Inventory Related Terms

Thank you for viewing the detailed overview of Extrawell Pharmaceutical Holdings's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Extrawell Pharmaceutical Holdings (HKSE:00858) Business Description

Traded in Other Exchanges
N/A
Address
979 King’s Road, Suites 2206-08, 22nd Floor, Devon House, Taikoo Place, Quarry Bay, Hong Kong, HKG
Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing; Trading and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. The gene development segment is engaged in the commercial exploitation and development of genome-related technology. Geographically, it derives a majority of its revenue from China.
Executives
Mao Yumin 2201 Interest of corporation controlled by you
Biowindow Gene Development (hong Kong) Limited 2201 Interest of corporation controlled by you
Ease Gold Investments Limited 2201 Interest of corporation controlled by you
Jnj Investments Ltd 2201 Interest of corporation controlled by you
United Gene Group Ltd 2201 Interest of corporation controlled by you
United Gene Holdings Limited 2201 Interest of corporation controlled by you
United Gene International Holdings Group Limited 2101 Beneficial owner
Xie Yi 2201 Interest of corporation controlled by you
Huang Zhenping 2101 Beneficial owner
United Gene Industry Group Limited 2101 Beneficial owner
Chen Xuhua 2202 Interest of your spouse
Cheng Yong 2201 Interest of corporation controlled by you

Extrawell Pharmaceutical Holdings (HKSE:00858) Headlines

No Headlines